Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to look at the effects of gantenerumab on the body in people with early Alzheimer’s disease

    A phase II, multicenter, open-label, single arm study to evaluate the pharmacodynamic effects of once weekly administration of gantenerumab in participants with early (prodromal to mild) Alzheimer’s disease

    • Neurodegenerative Disorder
    • Alzheimer's Disease (AD)